Press Release

This user hasn't shared any profile information

The Mayday Project Lyme patient advocacy group will host a forum on the scientific and policy challenges posed by the rapidly growing epidemic of Lyme disease and associated tick-borne illnesses. The forum...

Over the weekend we reported that the Philippines, one of four countries to approve the Sanofi Pasteur  dengue vaccine, Dengvaxia, and the first in Asia, were to commence the first dengue vaccine campaign...

The parasite responsible for a form of malaria now spreading from macaques to humans in South Asia could evolve to infect humans more efficiently, a step towards enhanced transmission between humans, according...

The Parkinson’s Disease Foundation® (PDF®) is calling upon communities around the US to join the team working to #EndParkinsons during April’s Parkinson’s Awareness Month. PDF urges...

They are young and mostly female: with more than 3.2 million reported cases between 2005 and 2014, chlamydia remains the most commonly reported sexually transmitted infection (STI) across Europe. As chlamydia...

Zoetis Inc. announced this week that the U.S. Department of Agriculture (USDA) has granted the company a conditional license for Avian Influenza Vaccine, H5N1 Subtype, Killed Virus*. The vaccine is intended...

The Vermont Fish & Wildlife Department is urging Vermont pet owners to ensure that their pets are properly vaccinated, after several sick and dying gray foxes, raccoons, and skunks have been discovered...

Every person deserves the chance to reach for their highest hopes and fulfill their greatest potential.  On World Autism Awareness Day, we reaffirm our dedication to ensuring that belief is a reality...

A team led by Purdue University researchers is the first to determine the structure of the Zika virus, which reveals insights critical to the development of effective antiviral treatments and vaccines. The...

Cambridge, Mass. biopharmaceutical company, Genocea Biosciences, Inc., announced this week positive 12 month efficacy data from its Phase 2 dose optimization trial evaluating GEN-003 for the treatment...